Week 1 Exam: NR565 / NR 565 (Latest 2026 / 2027) Advanced Pharmacology Fundamentals | Questions & Answers | 100% Correct | Grade A - Chamberlain

Week 1 Exam: NR565 / NR 565 (Latest 2026 / 2027) Advanced Pharmacology Fundamentals | Questions & Answers | 100% Correct | Grade A - Chamberlain Question: A nurse practitioner is prescribing a controlled substance. what additional information is required on the prescription? Answer DEA number Question: A nurse practitioner is prescribing a medication electronically using the clinic's electronic health records system. What is the benefit of e-prescribing in this situation? Answer Less medication errors Question: What is the primary responsibility when prescribing medications? Answer Ensuring patient safety through prudent and deliberate decision-making. Question: How should providers handle drug selections based on clinical practice guidelines and still provide individualized care? Answer Balance adherence to guidelines with consideration for individual patient needs Question: What is the recommended action for patients with altered CYP2C19 producing weak antiplatelet responses to clopidogrel? Answer Switch to a different antiplatelet drug Question: A 28-year-old patient Emily Jones presents to the clinic with symptoms of a skin infection. After evaluating.... Answer Take 1 capsule by mouth four times daily for 5 days Question: A 35- year- old patient, Jane Smith, presents to the clinic with symptoms of a urinary tract infection (UTI)... Answer Insufficient quantity Question: A 60-year-old patient, Mary Williams, presents to the clinic with symptoms of acute bronchitis.... Answer Incorrect directions for use Question: In addition to the prescriber's details, what may be required on a prescription based on state regulations for nurse practitioners (NPs)? Answer Supervising physician's details Question: A 45-year-old patient Sara Johnson, presents to the clinic with symptoms of a urinary tract infection (UTI), Allergic to Penivillin Answer Missing patient's allergy information Question: Pharmacodynamics Answer is the study of how drugs affect the body Question: pharmacokinetics Answer is the study of how the body affects the study of the way the body deals with the absorption, distribution, metabolism, and excretion of drugs under investigation expressed in mathematical terms. Question: Absorption: Answer Absorption is the process whereby a substance entering the body is assimilated by it. For proper pharmacokinetics study, it is necessary to know both the rate and the extent to which the active substance or therapeutic moiety are absorbed. They include substances intended to produce / not produce systematic effects. Question: Distribution: Answer Distribution is the dispersion or dissemination of substances throughout the fluids and tissues of the body. Question: Metabolism: Answer Metabolism is the process whereby a substance is irreversibly transformed into metabolites. Question: Excretion: Answer Sweat Excretion is the elimination of the substance from the body. In rare cases, not all substances are eliminated; some drugs irreversibly accumulate in a tissue in the body. Question: Agonist Answer A drug that binds to and activates a receptor. Can be full, partial or inverse. A full agonist has high efficacy, producing a full response while occupying a relatively low proportion of receptors. A partial agonist has lower efficacy than a full agonist. It produces sub-maximal activation even when occupying the total receptor population, therefore cannot produce the maximal response, irrespective of the concentration applied. An inverse agonist produces an effect opposite to that of an agonist, yet it binds to the same receptor binding-site as an agonist. Question: Antagonist Answer A drug that attenuates the effect of an agonist. Can be competitive or non-competitive, each of which can be reversible or irreversible. A competitive antagonist binds to the same site as the agonist but does not activate it, thus blocks the agonist's action. A non-competitive antagonist binds to an allosteric (non-agonist) site on the receptor to prevent activation of the receptor. A reversible antagonist binds non-covalently to the receptor, therefore can be "washed out". An irreversible antagonist binds covalently to the receptor and cannot be displaced by either competing ligands or washing. Question: BMax Answer The maximum amount of drug or radioligand, usually expressed as picomoles (pM) per mg protein, which can bind specifically to the receptors in a membrane preparation. Can be used to measure the density of the receptor site in a particular preparation. Question: Desensitization Answer A reduction in response to an agonist while it is continuously present at the receptor, or progressive decrease in response upon repeated exposure to an agonist. Question: Duration of Action Answer The duration of action of a drug is the length of time that particular drug is effective. Duration of action is a function of several parameters including plasma half-life, the time to equilibrate between plasma and target compartments, and the off rate of the drug from its biological target. Question: Efficacy Answer Describes the way that agonists vary in the response they produce when they occupy the same number of receptors. High efficacy agonists produce their maximal response while occupying a relatively low proportion of the total receptor population. Lower efficacy agonists do not activate receptors to the same degree and may not be able to produce the maximal response. Half-life Answer Half-life (t½) is an important pharmacokinetic measurement. The metabolic half-life of a drug in vivo is the time taken for its concentration in plasma to decline to half its original level. Half-life refers to the duration of action of a drug and depends upon how quickly the drug is eliminated from the plasma. The clearance and distribution of a drug from the plasma are therefore important parameters for the determination of its half-life. Mechanism of action (MOA) Answer Refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect. Potency Answer A measure of the concentrations of a drug at which it is effective. Silent Antagonist A drug that attenuates the effects of agonists or inverse agonists, producing a functional reduction in signal transduction. Affects only ligand-dependent receptor activation and displays no intrinsic activity itself. Also known as a neutral antagonist. Therapeutic Window The therapeutic window is the amount of a medication between the amount that gives an effect (effective dose) and the amount that gives more adverse effects than desired effects. For instance, medication with a small pharmaceutical window must be administered with care and control, e.g. by frequently measuring blood concentration of the drug, since it easily loses effects or gives adverse effects. State the three (3) most important characteristics of any drug. Effectiveness, safety, and selectivity. Is it possible to have a selective drug? No. All medications have side effects. What is one of the problems with trade names? Using two brand named drugs that have the same ingredient can lead to overdose What is the purpose of having a trade name (proprietary or brand name) for a drug? Trade names are easy to recall and pronounce, and good for marketing purposes. Which Amendment strengthened drug regulation after the Thalidomide tragedy in Europe? The Harris-Kefauver Amendment to the FDA and the Cosmetic Act of 1962 What is a "blinded" study? Participants don't know if they belong to the control or experimental group. What type of research is required to assess drug therapies? The randomized controlled trial is required for all new medications. What measures help reduce adverse reactions of medication administration? A thorough patient history to identify those who may be high-risk & education What factors can predispose an individual to adverse reactions from drugs? Allergies, pregnancy, age, genetics, & pathological disease (kidney or liver) Name the three most important goals of pre-administration assessment. Evaluate effects, identify high-risk patients, and assess for self care. Define pharmacodynamics. The nature and intensity of the response that the drug has on the body Define the four phases of pharmacokinetics. Absorption, distribution, metabolism, and excretion. There are two basic types of drug responses: quantal and graded. quantal response Quantal effects are responses that may or may not occur. If we designate a response as either occurring or absent, it is a quantal response. For example, Convulsions • Pregnancy • Rash • Sleep • Death Graded response Graded responses are biological effects that can be measured continually up to the maximum responding capacity of the biological system EXAMPLES OF GRADED RESPONSES TO DRUGS • Blood pressure • Heart rate • Diuresis • Bronchodilation • FEV1 • Pain (scale 1-10) • Coma score Selectivity ratio of the dose or concentration producing the undesired effect to the dose or concentration producing the desired effect therapeutic index is the ratio of the lethal dose of a drug to the therapeutic dose of a drug volume of distribution (VD) is a hypothetical value that reflects the volume in which a drug would need to be dissolved to explain the relationship between dosage and blood levels Which schedule drugs can APRNs prescribe? Antibiotics, antidepressants, and many other pharmaceuticals fall outside of these categories because they are considered noncontrolled substances. NPs can prescribe these medications, along with other Schedule II-V drugs. Schedule I - Heroin, LSD, Weed, Ecstasy Schedule II - Vicodin, cocaine, meth, oxycontin, adderall Schedule III - Testosterone, steroids, ketamine, Tylenol with condeine Schedule IV - Xanax, valium, Ativan, ambient, tramadol Schedule V - Robitussin, lomotil, motormen, Lyrica Who determines and regulates prescriptive authority? NP prescriptive authority be solely regulated by state boards of nursing and in accordance with the NP role, education and certification. The authorization of NPs to prescribe legend and controlled medications, devices, health care services, durable medical equipment and other equipment and supplies is essential to providing timely, cost-effective, quality health care. How does limited prescriptive authority impact patients within the healthcare system? States with reduced prescriptive authority have varying limitations on medications that NPs have the authority to prescribe to patients. NPs are categorized as restricted in the remaining twelve states and require physician supervision or delegation when prescribing controlled substances. What are the key responsibilities of prescribing? Evaluate and define the patient's problem. Determine the therapeutic objective of drug therapy. Select an appropriate medication. Provide patients with information, warnings, and instructions. Monitor the patient regularly. Consider drug costs when prescribing. Use appropriate tools, such as prescribing software and electronic drug references, to reduce prescription errors. What should be used to make prescribing decisions? Be clear about the reasons for prescribing Take into account the patient's medication history before prescribing Take into account other factors that might alter the benefits and harms of treatment Take into account the patient's ideas, concerns, and expectations Select effective, safe, and cost-effective medicines individualized for the patient Adhere to national guidelines and local formularies where appropriate Write unambiguous legal prescriptions using the correct documentation Monitor the outcomes of treatment, both beneficial and adverse Communicate and document prescribing decisions and the reasons for them Prescribe within the limitations of your knowledge, skills, and experience Be familiar with pharmacokinetic and pharmacodynamic changes of older adults and how that would translate to baseline information needed to prescribe. One of the most important pharmacokinetic changes associated with aging is decreased renal elimination of drugs. After age 40, glomerular filtration rate (GFR) decreases an average of 8 mL/min/1.73 m2/decade (0.1 mL/sec/m2/decade); however, the age-related decrease varies substantially from person to person. Beer's Criteria o What is it? o Why is it important? The AGS Beers Criteria® aims to guide older people and health professionals away from potentially harmful medications while also helping health systems recognize such decisions when assessing care quality. The most recent version of the Beers Criteria includes 30 medications or medication classes that most older individuals should avoid and 40 medications or medication classes that they should use with caution. Impacts/outcomes of polypharmacy The use of excessive or unnecessary medications — increases the risk of adverse drug effects, including falls and cognitive impairment, harmful drug interactions, and drug-disease interactions, in which a medication prescribed to treat one condition worsens another or causes a new one. CYP450 inhibitors o Examples o What do they do? o What do they cause if not used correctly? (aka: What would the patient experience?) The cytochrome P450 (CYP450) enzymes are essential to produce numerous agents, including cholesterol and steroids. They are also necessary for the detoxification of foreign chemicals and the metabolism of drugs. Drugs that cause CYP450 drug interactions are referred to as either inhibitors or inducers. Nowadays, the use of two or more drugs at the same time is quite common. This has the potential to cause drug interactions, thus increasing the risk of debilitating and even fatal adverse drug events. CYP450 inhibitors are used to minimize or prevent such reactions. CYP450 inhibitors are used: To prevent adverse events if you are on warfarin, antidepressants, antiepileptic, and statins As a harmacokinetic enhancer for HIV treatment: indicated to increase the systemic exposure of atazanavir or darunavir (once-daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection Side effects of CYP450 inhibitors may include: Severe toxicity Gastrointestinal disorders Genetic variability can influence CYP enzyme activity Brand names for CYP450 inhibitors drugs include: Cobicistat Tybost What happens when someone has a poor metabolism phenotype? Patients who are poor metabolizers (individuals with no CYP2D6 activity) or ultrarapid metabolizers (individuals with genetically elevated CYP2D6 activity) can have markedly altered response to drugs that are CYP2D6 substrates. Note that ethnic differences exist in CYP2D6 activity. What does the U.S. Food and Drug Administration regulate when it comes to medications? The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation. FDA reviews the drug's professional labeling and assures appropriate information is communicated to health care professionals and consumers. FDA inspects the facilities where the drug will be manufactured. FDA reviewers will approve the application or issue a response letter. Reasons for medication non-adherence Fear, Cost, Misunderstanding, Too many medications, Lack of symptoms, Mistrust, Worry, Depression Black Box Warnings o What are they? o Why are they issued? Black box warnings warn the public, but also alert doctors and other prescribers to serious side effects. Black box warnings, also called boxed warnings, are required by the U.S. Food and Drug Administration for certain medications that carry serious safety risks. Often these warnings communicate potential rare but dangerous side effects, or they may be used to communicate important instructions for safe use of the drug. Neonate and infant drug absorption o Be familiar with general development and when absorption would reach adult levels -Pediatric patients respond differently to drugs than the rest of the population -More sensitive to drugs than other patients are -Show greater individual variation -Sensitivity due mainly to organ system immaturity -Increased risk for adverse drug reactions -Ongoing growth & development (Absorption, Distribution, Hepatic metabolism, Renal excretion) Pharmacokinetics: Neonates and infants-Absorption: oral, intramuscular, percutaneous -Distribution: protein binding, blood-brain barrier -Determining the concentration of a drug at its sites of action -Determining the intensity of the duration of response Elevated drug levels = more intense response Delayed elimination = prolonged response Immaturity of organs puts patient at risk for both of these responses Common fears with genetic testing People may feel angry, depressed, anxious, or guilty about their results. In some cases, genetic testing creates tension within a family because the results can reveal information about other family members in addition to the person who is tested.